Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Has Public Reporting of Hospital Readmission Rates Affected Patient Outcomes?: Analysis of Medicare Claims Data J Am Coll Cardiol. 2016;67(8): doi: /j.jacc Impact of CMS Public Reporting Policies for Hospital Readmission: Trends for Acute MI 30-Day Readmission Rates CMS = Centers for Medicare and Medicaid Services; IPPS = inpatient prospective payment system; MI = myocardial infarction. Figure Legend:

Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Has Public Reporting of Hospital Readmission Rates Affected Patient Outcomes?: Analysis of Medicare Claims Data J Am Coll Cardiol. 2016;67(8): doi: /j.jacc Changes in Adjusted Trends for 30-Day Readmission Rates by Study Group The expected (solid lines) and observed (dotted lines) adjusted trends for 30-day readmission rates before and after implementation of public reporting for each study group: (A) acute myocardial infarction (MI); (B) heart failure; (C) pneumonia; (D) chronic obstructive pulmonary disease (COPD); and (E) diabetes. These trends are adjusted for patient demographics (age, sex, race) and comorbid conditions (cancer, COPD, cerebrovascular disease, dementia, diabetes, heart failure, hypertension, ischemic heart disease, liver disease, peptic ulcer disease, peripheral vascular disease, renal disease, rheumatic disease, valvular heart disease) and account for clustering of patients within hospitals. Figure Legend:

Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Has Public Reporting of Hospital Readmission Rates Affected Patient Outcomes?: Analysis of Medicare Claims Data J Am Coll Cardiol. 2016;67(8): doi: /j.jacc Changes in Adjusted Trends for 30-Day Post-Discharge Mortality by Study Group The expected (solid lines) and observed (dotted lines) adjusted trends for 30-day post-discharge mortality before and after implementation of public reporting for each study group: (A) acute myocardial infarction (MI); (B) heart failure; (C) pneumonia; (D) chronic obstructive pulmonary disease (COPD); and (E) diabetes. Adjusted for patient demographics (age, sex, race) and comorbid conditions (cancer, COPD, cerebrovascular disease, dementia, diabetes, heart failure, hypertension, ischemic heart disease, liver disease, peptic ulcer disease, peripheral vascular disease, renal disease, rheumatic disease, valvular heart disease), and accounts for clustering of patients within hospitals. Figure Legend: